SNAP-8 Reference

Cosmetic octapeptide · Cosmetic ingredient

ClassCosmetic octapeptide
StatusCosmetic ingredient
Typical vials10 mg, 20 mg
Dose range0.5 mg to 2 mg
FrequencyDaily topical application
Half-lifeNo human data
Dosing unitmilligrams
RouteTopical, in cosmetic solutions (not injected)

What SNAP-8 is

SNAP-8 is an eight-amino-acid extension of Argireline, a fragment of the SNARE-complex protein SNAP-25, marketed as a topical botox-alternative that damps the muscle-contraction signaling behind expression lines. The supporting evidence is manufacturer in-vitro work and small cosmetic studies, not clinical trials. It is applied to skin, never injected; it appears in this reference because it ships as the same lyophilized vials as everything else and the reconstitution math is identical.

What we do not know

  • The supporting evidence is manufacturer in-vitro work and small cosmetic studies, not independent clinical trials.
  • It is a topical ingredient. There is no evidence of any kind for injecting it, which is the context the reconstitution math on this page usually implies.
  • Effect sizes in the cosmetic literature are measured against untreated skin over weeks, with the usual difficulty of blinding a wrinkle assessment.

Reconstitution math

Concentration is everything: the same 10 mg vial gives a different draw for every amount of bacteriostatic water you add. The table uses the common 2 mL setup for each vial size, which puts every unit on a U-100 insulin syringe at 50 mcg for the default vial. Dashes mark draws too small to measure or larger than the syringe.

VialBAC waterConcentration0.5 mg1 mg2 mg
10 mg2 mL5 mg/mL10 u20 u40 u
20 mg2 mL10 mg/mL5 u10 u20 u
SNAP-8 syringe drawsDRAW GUIDEEach dose as a filled syringe10 mg vial + 2 mL bacteriostatic water = 0.5 mg per 0.1 mL (10 units).0481216202428323640units on a U-100 insulin syringe (first 40 units shown)0.5 mg10 u (0.1 mL)1 mg20 u (0.2 mL)2 mg40 u (0.4 mL)peprecon.com
Draw positions for the common doses at the default setup.

Dosing and protocol

Cosmetic use: reconstituted solution mixed into serums or applied directly, typically 0.5 to 2 mg per mL of finished product, on expression-line areas daily.

Users reconstitute the vial and blend it into a serum or apply the solution directly to expression-line areas (forehead, crow's feet) daily. Common finished-product strength is 0.5 to 2 mg per mL, so a 10 mg vial makes 5 to 20 mL of serum. The syringe figures here are for measuring while mixing, not for injection. Refrigerate the made-up solution like any reconstituted peptide.

Pharmacokinetics

No curve is shown, on purpose.

SNAP-8 is a topical cosmetic ingredient; it acts locally in skin and is not meaningfully absorbed to circulation. Systemic pharmacokinetics do not apply to how it is used.

How it is thought to work

An eight-amino-acid extension of Argireline, itself a fragment of the SNARE protein SNAP-25. The proposed action is competitive interference with SNARE complex assembly, damping the acetylcholine release behind expression lines. It is a cosmetic ingredient, applied to skin.

How SNAP-8 is thought to workMECHANISMSNAP-8: the proposed chainA proposed pathway. The last step is the one that needs evidence in people.1Applied to the skinA cosmetic ingredient rather than an injectable.2An eight-residue extension of Argireline, itself a fragment of SNAP-253Competitive interference with SNARE complex assemblyProposed to damp the acetylcholine release behind expression lines.4Softened expression linesThe open question is whether a peptide this size crosses intact skin at all.STRONGEST PUBLISHED EVIDENCE FOR ANY CLAIMED OUTCOMEHuman, observationalOutcome by outcome, see the table below.peprecon.com

What the evidence supports

This table grades how well each outcome has been studied in humans, not how well SNAP-8 works. A strong grade means the question was asked properly, and the answer may still have been negative. Nothing here is inherited from a drug class, a close analog, or the parent molecule of a fragment.

OutcomeStrongest published evidence
Wrinkle appearance, topicalHuman, observational
SNARE complex interferenceMechanistic only
Any outcome from injectionNo data
Human, observationalReported in people without randomization: open-label, single-arm, retrospective, or case series.
Mechanistic onlySupported only by cell, tissue or biochemical work, or by reasoning from a related molecule.
No dataNo published evidence at any level that we could find.

Storage and handling

Lyophilized vials keep best cold, dark, and dry; refrigeration is the community default and freezing lyophilized powder is common for long holds. After reconstitution, refrigerate at 2 to 8 C, do not freeze the solution, and date the vial. Bacteriostatic water's preservative keeps multi-dose use practical for about 28 days by USP convention, though our 120-day stability study found the preservative itself outlasts that window.

Got a certificate of analysis with your vial? Run it through our COA Reader: it reads the report in plain English, checks purity and mass against the label claim, and links the testing lab’s own verification page. Our guide to reading a COA explains what the numbers do and do not tell you.

Sources

  1. Blanes-Mira et al., A synthetic hexapeptide (Argireline) with antiwrinkle activity, Int J Cosmet Sci 2002PMID 18498523 · DOI
  2. Lipotec/Lubrizol SNAP-8 technical dossier (manufacturer data)Manufacturer data

Related references: GHK-Cu · KPV